Cash Flow from Operating Activities: A company's cash flows from operations.
Armata Pharmaceuticals, Inc. (ARMP) had Cash Flow from Operating Activities of $-5.78M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.79M |
|
$-115.35M |
|
-- |
|
$0.79M |
|
$9.57M |
|
$-8.79M |
|
$-106.56M |
|
$-115.35M |
|
$-115.35M |
|
$-115.35M |
|
$-115.35M |
|
$-115.35M |
|
$-115.35M |
|
$-8.79M |
|
$-8.33M |
|
36.53M |
|
36.53M |
|
$-3.16 |
|
$-3.16 |
|
| Balance Sheet Financials | |
$5.95M |
|
$11.78M |
|
$63.85M |
|
$69.80M |
|
$9.23M |
|
$342.90M |
|
$372.16M |
|
$381.39M |
|
$-311.59M |
|
$-315.08M |
|
$-311.59M |
|
36.65M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-5.78M |
$-0.06M |
|
$0.64M |
|
$14.08M |
|
$8.87M |
|
$-5.20M |
|
$1.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.64 |
|
-- |
|
-- |
|
10.95 |
|
-1.10 |
|
100.00% |
|
-1113.43% |
|
-1113.43% |
|
-- |
|
-14619.27% |
|
-14619.27% |
|
$-5.84M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
16.79 |
|
5.36 |
|
37.02% |
|
36.61% |
|
-165.25% |
|
-368.38% |
|
$-8.50 |
|
$-0.16 |
|
$-0.16 |
|